官方服务：
资源简介：
TKI258_FGFR_INHIBITOR_TREATMENT
应用场景：
创建时间：
2013-02-17
相关数据集
SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
Protein arginine methyltransferase 5 (PRMT5) over-expression in hematological and solid tumors methylates arginine residues on cellular proteins involved in important cancer functions including cell c
NIAID Data Ecosystem90
Subsequent treatments after progression on CDK 4/6 inhibitors.
Subsequent treatments after progression on CDK 4/6 inhibitors.
NIAID Data Ecosystem70
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53R249S Mutation and Is a Potential Therapeutic Target
TP53 mutations are highly associated with hepatocellular carcinoma (HCC), a common and deadly cancer. However, few primary drivers in the progression of HCC with mutant TP53 have been identified. To u
科学数据银行2025-09-11 更新30
肿瘤靶分子临床研究信息数据集
聚焦肿瘤靶分子临床研究全流程，整合靶点发现、临床试验设计、疗效数据、安全性评估等核心信息。数据经标准化清洗与专业校验，关联靶点分子结构、作用机制及临床结果，支持科研机构靶点验证、药企药物研发、临床机构方案优化，为靶分子临床转化提供高质量、可溯源的数据支撑。
江苏数据交易所80
Ganglioside GD2 identifies Breast Cancer Stem Cells: Targeting GD3 Synthase Inhibits GD2 Expression and Tumor Growth. Homo sapiens
We FACS sorted Ras-transformed human mammary epithelial cells (HMLER cells) into GD2+ and GD2- as well as CD44high/CD24low and CD44low/Cd24highcells and comapred the four different population by array
NIAID Data Ecosystem30
